CRISPR mediated PAK4 knockdown results in inhibited cell proliferation, migration and invasion and reduced monolayer permeability in human glioblastoma (GBM) derived tumor endothelial cells (EC) and leads to a normalization of the tumor vasculature and enhanced T cell infiltration. Here, PAK4 is linked to glioblastoma.